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Challenge Unmet for DecadesCongenital malformations (CMs), or birth defects, cause
significant morbidity and mortality in newborns. From the
1970s to the 1990s, the prevalence of CMs was 33.9 per 1000
live births in the United States.1 In the current issue of this
journal, Egbe et al2 report the prevalence of CMs in 2008 as
28.9 per 1000 live births, which provides important follow-
up data from the United States. Although these results are
similar to those from the 1970s up to 2008, they reflect the
nationwide prevalence. However, it is surprising that over
these years, the prevalence of CMs has not appreciably
decreased. This stability might be due to the detection of
certain CMs in the third trimester, which exceeds the legal
period for termination. In addition, owing to improvements
in postnatal surgical and medical care, several CMs can be
corrected after birth, and, therefore, such cases need not
be terminated. A third explanation is the decision of the
parents based on different cultures and religions.
Compared with the estimated prevalence of CMs in the
United States of 47.2 per 1000 live births according to a
report by the March of Dimes,3 the prevalence of CMs is
higher in Middle Eastern and African counties, at up to 70 per
1000 live births, whereas that in the European countries is
lower, at approximately 40 per 1000 live births. This result
correlates with the national income, as higher-income
countries display a lower CM prevalence.3 Compared with
other countries, the reported prevalence of CMs in Taiwan is
surprisingly low; a report from the birth registry in 2002
revealed that the prevalence of CMs was 7 per 1000 live
births.4 This result might be due to underreporting or the
higher abortion rate of prenatally identified cases in Taiwan.
There are two predominant methods to collect CM
data. One method is the use of birth registries, which are
primarily managed by obstetricians. The other method is
the examination of the International Classification of Dis-
eases, Ninth Revision (ICD-9), codes from a hospital or
insurance system. Based on our experience, the birth
registry system tends to report a lower identification ratehttp://dx.doi.org/10.1016/j.pedneo.2014.11.002
1875-9572/Copyright ª 2014, Taiwan Pediatric Association. Published bthan the ICD-9 codes. This disparity occurs because some
CMs may not be identified at birth, although in the current
pediatric practice setting, CMs in newborns are typically
easily identified based on careful physical examination
and the availability of sonography screening before
discharge.
The role of pediatricians for patients with CM is to pro-
vide basic care, to rapidly recognize various types of CMs,
and to provide basic treatment and counseling, as well as to
refer the patient to a specialist when necessary.5 The eti-
ology of CM is categorized as follows: 25% of CMs are caused
by a chromosomal anomaly; 20% are caused by a single-
gene disorder; 5% are caused by an environmental factor;
and approximately 50% are caused by multiple factors.6
Elucidating the etiology of a CM helps prevent a future
CM in subsequent pregnancies, especially for those that are
due to inherited genetic disorders, which display a high
recurrence risk; only accurate diagnosis assists in guiding
prenatal care.
The strategies for the prevention of CM include envi-
ronmental protection, genetic counseling, and prenatal
surveillance. Recently, because of technical progress in
preimplantation diagnosis, the increased availability of the
noninvasive fetal trisomy (NIFTY) test, and the application
of next-generation sequencing or array comparative
genomic hybridization, the prenatal diagnosis of genetic
syndromes and CMs has increased. In 2010, the World
Health Organization announced an action to prevent CMs
via the following strategies: family planning, preconception
screening, and counseling; optimization of women’s diet
before and throughout pregnancy; prevention and treat-
ment of teratogen-induced infections; and the optimization
of maternal health, antenatal screening, prenatal diag-
nosis, and fetal treatment using nationwide policy- and
public health-based approaches.5 We hope that their ef-
forts will dramatically decrease the prevalence of CMs in
the near future.y Elsevier Taiwan LLC. All rights reserved.
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